Skip to main content

and
  1. Article

    Open Access

    Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR-D17-00693)

    After the publication of this article [1], we noticed that in Fig. 2, the survival curve images (C and D, lower panel) were incorrect. The corrected Fig. 2 is presented below. The correction does not affect in...

    Aya Asano, Shigeto Ueda, Ichiei Kuji, Tomohiko Yamane in Breast Cancer Research (2018)

  2. Article

    Open Access

    Intracellular hypoxia measured by 18F-fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen receptor-positive breast cancer

    Hypoxia is a key driver of cancer progression. We evaluated the prognostic impact of 18F-fluoromisonidazole (FMISO) prior to treatment in patients with breast cancer.

    Aya Asano, Shigeto Ueda, Ichiei Kuji, Tomohiko Yamane in Breast Cancer Research (2018)